Videos

Kimberly Maxfield, PhD, discussed pharmacist’s role to aid patients when switching to a biosimilar

In this field, Marshall notes that pharmacists can help by building forecasts and assist with managing members’ care before and after gene therapy.

Lisa Schrade, PharmD, discusses factor replacement therapies and emicizumab’s role in treating hemophilia.

Experts explore the impact of hemophilia on patients’ lives, economic impact, and the crucial role of specialty pharmacists.

Jensen notes that although she expects there will be a lot of FDA approvals in 2023 and 2024, there likely will not be another biosimilar “boom” until 2025.

Jeff J, Mclntyre, MA, Vice President of Liver Health Programs, Global Liver Institute, discussed the clinical and economic burden of NASH

Medically integrated dispensing specialty pharmacies can connect patient medical and pharmacy records to improve medication adherence and help patients to safely stay on them for longer.

Grace Yun, PharmD, and pharmacy manager at St. Francis Hospital, discussed the value of the pharmacist and how she sees the future of pharmacy evolving.

A specialist in adult, child, and adolescent psychiatry discusses the challenges in ADHD treatment for both patients and providers, as well as insights from a recent survey of health care professionals.

In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.

These pharmacies can use electronic medical records to work more directly with providers, monitoring adverse medication effects and assessment schedules and being more tuned into patient needs.

Kimberly Westrich, MA, discussed value assessment tools and how they can help make key decisions in health care spending.

Laura Chambers, DO, drives a conversation surrounding the impact of misinformation on gynecologic cancers that is spread through social media.

Celebrate pharmacy technicians and their crucial role in the pharmacy ecosystem.

Margaret Ryman, BS, PharmD, BCPS, vice president of Health Systems at McKesson, discussed how she has seen the pharmacy field change and how she is celebrating this American Pharmacists Month.

Sindhuja Merugu, pharmacy technician at Health Mart Family Pharmacy discusses the role of the pharmacy technician, how the pharmacy technician profession has changed, and what is to come in the field.

Dr Moore examines findings from the NATALEE trial.

The pharmacist’s role in addressing treatment failure for patients receiving CDK4/6 inhibitors is examined.

Rose DiMarco, PharmD, BCPS, BCOP, addresses strategies to maximize patient adherence to CDK4/6 inhibitor therapy.

Karline Peal, MBA of Vanderbilt Ingram Cancer Center discusses the positive impact technology has had in health care and how it can be implemented in the future.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses being the second pharmacist in IDSA history to receive a society award and what this means not only for her, but for the field.

Jennifer Mathieu, MA from the Academy of Managed Care Pharmacy (AMCP) discusses what to expect from AMCP Nexus 2023 and some of the sessions she is looking forward to.

With walkouts across the country and other efforts to raise public awareness, pharmacists are working to find solutions to understaffing and workload challenges.

Within this care model, pharmacists can serve an important role in caring for patients, whether it is identifying adverse medication interactions or pushing patients to seek additional support.

Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.

Heather Moore, CPP, PharmD, BCOP, highlights the impact of pharmacists in adverse effect profile management for CDK4/6 inhibitors.

A description of the SONIA study is provided by Heather Moore, CPP, PharmD.

Hormone therapy in metastatic breast cancer management is examined by key opinion leaders.

With World Standards Week on October 10 to 12, 2023, it is a key time to assess preparation for the official date for revised USP General Chapters <795> and <797> on compounding, as well as the associated USP General Chapter <800> on the handling of hazardous drugs in healthcare settings.

Naveen Mansukhani, BPharm, National Operations Director for Cardinal Health Retail Pharmacy Services, discussed how he is celebrating American Pharmacists Month.